Literature DB >> 23532332

A Wnt-er migration: the confusing role of β-catenin in melanoma metastasis.

Marie R Webster1, Ashani T Weeraratna.   

Abstract

Wnt signaling in melanoma is complex, requiring the coordinate expression of multiple players. Depending on the context of receptors and co-receptors that are present, Wnt proteins may signal through either canonical or noncanonical pathways. The role of β-catenin in melanoma metastasis remains unclear; however, a new study points to the roles of Wnt5A and ARF6 in driving β-catenin expression and melanoma metastasis. Here, we discuss this finding and how it may help us define different subpopulations of melanoma cells that could have different outcomes, as well as different responses to therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23532332     DOI: 10.1126/scisignal.2004114

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  37 in total

Review 1.  Can we safely target the WNT pathway?

Authors:  Michael Kahn
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

Review 2.  Signal pathways of melanoma and targeted therapy.

Authors:  Weinan Guo; Huina Wang; Chunying Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-20

3.  RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

Authors:  Tomasz Radaszkiewicz; Michaela Nosková; Kristína Gömöryová; Olga Vondálová Blanářová; Katarzyna Anna Radaszkiewicz; Markéta Picková; Ráchel Víchová; Tomáš Gybeľ; Karol Kaiser; Lucia Demková; Lucia Kučerová; Tomáš Bárta; David Potěšil; Zbyněk Zdráhal; Karel Souček; Vítězslav Bryja
Journal:  Elife       Date:  2021-10-27       Impact factor: 8.140

4.  Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro.

Authors:  Tobias Maier; Stefan Stoiber; Lorenz Kadletz-Wanke; Faris F Brkic; Elisabeth Gurnhofer; Markus Haas; Lukas Kenner; Gregor Heiduschka
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-24       Impact factor: 3.236

Review 5.  Targeting the WNT Signaling Pathway in Cancer Therapeutics.

Authors:  David Tai; Keith Wells; John Arcaroli; Chad Vanderbilt; Dara L Aisner; Wells A Messersmith; Christopher H Lieu
Journal:  Oncologist       Date:  2015-08-25

6.  Hypoxia induces phenotypic plasticity and therapy resistance in melanoma via the tyrosine kinase receptors ROR1 and ROR2.

Authors:  Michael P O'Connell; Katie Marchbank; Marie R Webster; Alexander A Valiga; Amanpreet Kaur; Adina Vultur; Ling Li; Meenhard Herlyn; Jessie Villanueva; Qin Liu; Xiangfan Yin; Sandy Widura; Janelle Nelson; Nivia Ruiz; Tura C Camilli; Fred E Indig; Keith T Flaherty; Jennifer A Wargo; Dennie T Frederick; Zachary A Cooper; Suresh Nair; Ravi K Amaravadi; Lynn M Schuchter; Giorgos C Karakousis; Wei Xu; Xiaowei Xu; Ashani T Weeraratna
Journal:  Cancer Discov       Date:  2013-10-08       Impact factor: 39.397

Review 7.  Developmental pathways activated in melanocytes and melanoma.

Authors:  Jianglan Liu; Mizuho Fukunaga-Kalabis; Ling Li; Meenhard Herlyn
Journal:  Arch Biochem Biophys       Date:  2014-08-08       Impact factor: 4.013

8.  ATG5 Mediates a Positive Feedback Loop between Wnt Signaling and Autophagy in Melanoma.

Authors:  Abibatou Ndoye; Anna Budina-Kolomets; Curtis H Kugel; Marie R Webster; Amanpreet Kaur; Reeti Behera; Vito W Rebecca; Ling Li; Patricia A Brafford; Qin Liu; Y N Vashisht Gopal; Michael A Davies; Gordon B Mills; Xiaowei Xu; Hong Wu; Meenhard Herlyn; Michael C Nicastri; Jeffrey D Winkler; Maria S Soengas; Ravi K Amaravadi; Maureen E Murphy; Ashani T Weeraratna
Journal:  Cancer Res       Date:  2017-09-08       Impact factor: 12.701

9.  Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.

Authors:  Marie R Webster; Mitchell E Fane; Gretchen M Alicea; Subhasree Basu; Andrew V Kossenkov; Gloria E Marino; Stephen M Douglass; Amanpreet Kaur; Brett L Ecker; Keerthana Gnanapradeepan; Abibatou Ndoye; Curtis Kugel; Alexander Valiga; Jessica Palmer; Qin Liu; Xiaowei Xu; Jessicamarie Morris; Xiangfan Yin; Hong Wu; Wei Xu; Cathy Zheng; Giorgos C Karakousis; Ravi K Amaravadi; Tara C Mitchell; Filipe V Almeida; Min Xiao; Vito W Rebecca; Ying-Jie Wang; Lynn M Schuchter; Meenhard Herlyn; Maureen E Murphy; Ashani T Weeraratna
Journal:  Mol Cell       Date:  2019-12-11       Impact factor: 17.970

10.  PLEKHA4 Promotes Wnt/β-Catenin Signaling-Mediated G1-S Transition and Proliferation in Melanoma.

Authors:  Adnan Shami Shah; Xiaofu Cao; Andrew C White; Jeremy M Baskin
Journal:  Cancer Res       Date:  2021-02-11       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.